s6y

Solventum Corp

Ticker
SOLV
CIK
1964738
Industry
Surgical & Medical Instruments & Apparatus
Formerly
3M Health Care Co

Financials 11

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 11 financials filings

News 33

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 33 news filings

Ownership 158

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 158 ownership filings

Prospectus 21

  1. 424B7 Prospectus filed pursuant to Rule 424(b)(7)
  2. 424B7 Prospectus filed pursuant to Rule 424(b)(7)
  3. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  4. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-4 Registration of securities issued in business combination transactions
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. DRSLTR Correspondence Related to Draft Registration Statement
  9. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  10. DRSLTR Correspondence Related to Draft Registration Statement

All 21 prospectus filings

Proxies 4

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  4. DEF 14A Definitive proxy statements

Other 37

  1. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
  2. SCHEDULE 13G
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. SCHEDULE 13G/A
  7. SCHEDULE 13G
  8. SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
  9. ARS Annual report to security holders
  10. IRANNOTICE Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

All 37 other filings